A3P

Log in

Sanofi launches a laboratory dedicated to e-health

The pharmaceutical group Sanofi inaugurated Monday in Gentilly (Val-de-Marne) 39Bis, its first laboratory dedicated to e-health, which is defined by the use of digital tools to improve the quality of care.

Read more...

Multiple sclerosis: Sanofi joins forces with American biotech

Sanofi and US biotech Principia announced Thursday an agreement, worth up to 765 million, to develop a treatment for multiple sclerosis.

Read more...

Novartis to buy Advanced Accelerator Applications laboratory

The Swiss pharmaceutical giant Nobartis announced on Monday an offer to buy the French laboratory of radiopharmacy Advanced Accelerator Applications (AAA), strengthening its activities in oncology.

Read more...

Health: Should French nuggets go abroad to finance themselves?

The acquisition of the French radiopharmacy laboratory, Advanced Accelerator Applications (AAA), by the Swiss giant Novartis Monday is not a first: regularly, French nuggets in the health sector pass under foreign flag, failing to finance in the hexagon.

Read more...

Transgene relies on its clinical trials for 2018

Biotech company Transgene said Thursday, when it published its results, that it expected 2018 clinical results for five of its seven products currently tested.

Read more...

a3p-100pxhaut logo

 fren

Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb - drapeauitalie )


  group    administrators A3P
    
& Project Managers

letter   newsletter A3P